Recro Pharma, Inc. (REPH): Headwinds and Tailwinds

Price Performance of Recro Pharma, Inc. (REPH)

Recro Pharma, Inc. (NASDAQ:REPH) has experienced an interesting year when it comes to its price journey. This particular company’s stock managed to reach its 1-Year High price of $13.05 on 05/23/18, but it dropped to its lowest point in the past year, $4.78 on 06/29/18.

At the end of the most recent trading day, Recro Pharma, Inc. closed at $9.72. The stock began the trading session at $9.79 and hit a high of $10.25. The lowest price during the trading day was $9.67.

The shares of this company, which operates in the healthcare sector, reached a trading volume of about 576,381 throughout the day, which was clearly higher than the average daily volume for these shares.

At the time of writing, this publicly-traded organization holds a total market value of 207.28M, with 255 employees on its payroll.

Continuing forward, if we take into consideration what stock market experts are currently saying regarding Recro Pharma, Inc.(NASDAQ:REPH), the mean rating for this stock is 1.40. How is that calculated? Well, 3 analysts have given this company a BUY rating, 2 are rated it as OUTPERFORM, 0 have recommended that investors HOLD, 0 are considering it an UNDERPERFORM and 0 have recommended that owners of these shares SELL.

A month ago, 3 analysts thought this stock was a BUY, 2 of them posted an OUTPERFORM rating, 0 analysts recommended to HOLD this stock, 0 of them provided an underperform rating and 0 rated it as a Sell.

For REPH stock, the reported Earnings Per Share trailing twelve months is sitting at -76.10%. Meanwhile, operating margin is currently observed to be -69.90% and its Gross Margin trailing twelve months is 44.20%.

Technical analysis

This company’s 100-day moving average was 7.80, while its price change was posted at +2.91. Similarly, Recro Pharma, Inc. (NASDAQ:REPH) experienced a 100-day Percent movement of +42.70% with a trading volume reaching 167,072.

Continuing to look at similarly important data, this stock’s distance from its 200-day Simple Moving Average, or SMA 200, is 38.73% at the time of writing. This organization’s revenue over the trailing twelve months (TTM) of active operations is 77.30M, considering the fact that it was able to rack up the income of -$79.70M through that period of time.

While maintaining our attention on the Technical analysis of Recro Pharma, Inc. (NASDAQ:REPH), during the last 50 days, its Raw Stochastic average was observed 79.52%, representing an improvement from this organization’s 20-day Raw Stochastic average – which was posted 71.32%. During the last 20-days time span, this firm’s Stochastic %K was 61.09% and its Stochastic %D was noted 52.35%.

When looking deeper into the past price path that shares of Recro Pharma, Inc. (NASDAQ:REPH) have taken, we can observe multiple moving trends. This particular stock’s current year-to-date (YTD) price performance is standing at 36.87%. Meanwhile, during the past six months of trading, this stock has improved to 29.57%, along with a full-year performance of -18.06%. This company’s shares increased nearly 2.59% during the last 7-day stretch and fell 5.17% over the last 30 days.